Michigan Inventors Coalition: Pharma Insights

Medication-Induced Hair Loss: Causes and What You Can Do

By Joe Barnett On 2 Dec, 2025 Comments (10)

Medication-induced hair loss is common and often reversible. Learn which drugs cause it, how long it lasts, and what actually works to get your hair back-backed by science and real patient data.

Cancer Prevention: How Lifestyle and Chemoprevention Reduce Your Risk

By Joe Barnett On 1 Dec, 2025 Comments (12)

Learn how lifestyle choices like diet, exercise, and avoiding tobacco can cut your cancer risk by up to 21%. Discover what chemoprevention really means-and who it’s for. Science-backed, practical steps anyone can take.

Why Prices Drop at Launch: The Real Reason First Generic Entries Crush Costs

By Joe Barnett On 1 Dec, 2025 Comments (10)

First generic entries trigger massive price drops because they offer enough functionality at a fraction of the cost. This shift forces incumbents to lower prices or lose market share - a trend accelerating across software, healthcare, and tech.

Lower GI Bleeding: Diverticula, Angiodysplasia, and How Doctors Diagnose It

By Joe Barnett On 30 Nov, 2025 Comments (11)

Lower GI bleeding is often caused by diverticula or angiodysplasia, especially in older adults. Learn how doctors diagnose and treat these conditions, what to expect, and when to seek help.

Oral Care for Dry Mouth: Best Products and Daily Habits That Actually Work

By Joe Barnett On 29 Nov, 2025 Comments (11)

Dry mouth isn't just annoying-it raises your risk of cavities and gum disease. Learn the best products like Biotène and ACT, plus simple daily habits that actually work to relieve dry mouth and protect your teeth.

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett On 28 Nov, 2025 Comments (14)

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

Insulin, EpiPens, and Nitroglycerin: What Happens When They Expire?

By Joe Barnett On 27 Nov, 2025 Comments (14)

Expired insulin, EpiPens, and nitroglycerin can fail when you need them most-leading to hospitalization or death. Learn the real risks, storage rules, and what to do if you can't afford replacements.

Opioid Itching vs. Allergy: How to Tell the Difference and What to Do

By Joe Barnett On 26 Nov, 2025 Comments (9)

Itching after opioids like morphine is usually not an allergy - it's a common side effect. Learn how to tell the difference between harmless itching and a true allergic reaction, and what to do to get effective pain relief without unnecessary risks.

Generic Pill Appearance Changes: Safety, Legality, and Patient Impact

By Joe Barnett On 25 Nov, 2025 Comments (12)

Generic pills can change color, shape, or size without affecting their effectiveness - but many patients stop taking them because of the confusion. Learn why this happens, how to stay safe, and what you can do to avoid dangerous mistakes.

Global Health Access: How Generics Are Changing Medicine in Low-Income Countries

By Joe Barnett On 22 Nov, 2025 Comments (8)

Generics can cut medicine costs by 80%, yet billions in low-income countries still can't access them. Discover why affordable drugs aren't reaching those who need them most-and what’s being done to fix it.

Crossing Time Zones with Insulin: Adjusting Doses Safely for Travelers with Diabetes

By Joe Barnett On 21 Nov, 2025 Comments (18)

Traveling across time zones with insulin requires careful dose adjustments to avoid dangerous blood sugar swings. Learn how to safely adjust your insulin for eastbound and westbound flights, what experts recommend, and what to pack for a trouble-free trip.

Asian Generic Markets: How India and China Dominate Global Pharma Supply

By Joe Barnett On 20 Nov, 2025 Comments (8)

India and China dominate the global generic drug market, supplying over 70% of the world's medicines. India leads in volume and affordability, while China controls the supply of active ingredients and is moving into high-value biologics. Emerging economies like Vietnam and Cambodia are carving out niche roles in this complex ecosystem.